News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: None

Thursday, 07/26/2007 7:09:05 AM

Thursday, July 26, 2007 7:09:05 AM

Post# of 3757
Baraclude now selling at $236M annual run rate:

http://biz.yahoo.com/prnews/070726/nyth051.html?.v=101

>>
Sales of BARACLUDE, an oral antiviral agent for the treatment of chronic hepatitis B, increased to $59 million in the second quarter of 2007 from $14 million in the same period in 2006, due to continued growth across all markets.

<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”